Milestone completes studies with its epidural instrument
by Katie Pfaff
Drug delivery instrument company, Milestone Scientific Inc., has shared positive results of a pair of studies with its CompuFlo Epidural instrument. The device is also being used at an undisclosed academic veterinary institution to complete treatment in horses in maxillary nerve block procedures.
“This institution’s team continually leads the way in advancements in veterinary medicine, and we are honored to provide them with our proven technology,” said Arjan Haverhals, chief executive officer of Milestone Scientific. “Milestone is continually evaluating additional channels to commercialize our technology, including new medical indications. Veterinary medicine is just one example of another market that will benefit from our CompluFlo Epidural instrument. We believe the extensive prior studies, spanning epidural, peripheral nerve block, intra-articular, and veterinary use cases reinforce the enhanced safety, improved outcomes, economic benefits, and broad market potential of our instrument.”
A 2020 published study on the company’s equine maxillary nerve block indicated the tool could be used to teach veterinary students on the procedure and increased the likelihood of success as the tool helped to guide the user.
“I am excited to see commercial uptake of the CompuFlo Epidural instrument in clinical practice, as well as in the classroom to educate the next generation of veterinarians,” said Dr. Bernd Driessen, equine anesthesiologist and participant in earlier CompuFlo clinical trials. “The CompuFlo Epidural instrument can provide fellow veterinarians and students greater accuracy through real-time verification of needle location when performing a maxillary nerve block.”
Comments
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment